Quest Diagnostics Incorporated (DGX)

NYSE: DGX · Real-Time Price · USD
167.96
-1.32 (-0.78%)
At close: Apr 2, 2025, 4:00 PM
168.69
+0.73 (0.43%)
After-hours: Apr 2, 2025, 5:16 PM EDT
-0.78%
Market Cap 18.64B
Revenue (ttm) 9.87B
Net Income (ttm) 866.00M
Shares Out 110.98M
EPS (ttm) 7.69
PE Ratio 21.84
Forward PE 17.34
Dividend $3.20 (1.91%)
Ex-Dividend Date Apr 7, 2025
Volume 940,539
Open 170.00
Previous Close 169.28
Day's Range 167.26 - 170.41
52-Week Range 125.42 - 178.87
Beta 0.78
Analysts Buy
Price Target 179.57 (+6.91%)
Earnings Date Apr 22, 2025

About DGX

Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It also provides diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans,... [Read more]

Sector Healthcare
IPO Date Dec 17, 1996
Employees 56,000
Stock Exchange NYSE
Ticker Symbol DGX
Full Company Profile

Financial Performance

In 2024, Quest Diagnostics's revenue was $9.87 billion, an increase of 6.70% compared to the previous year's $9.25 billion. Earnings were $866.00 million, an increase of 1.88%.

Financial Statements

Analyst Forecast

According to 14 analysts, the average rating for DGX stock is "Buy." The 12-month stock price forecast is $179.57, which is an increase of 6.91% from the latest price.

Price Target
$179.57
(6.91% upside)
Analyst Consensus: Buy
Stock Forecasts

News

Quest Diagnostics Introduces HPV Specimen Self-Collection for Cervical Cancer Screening

Providers in the United States may now order the FDA-cleared HPV self-collection solution for their patients to use in their offices or other healthcare settings, with goal to reduce barriers to scree...

10 hours ago - PRNewsWire

Quest Diagnostics to Release First Quarter 2025 Financial Results on April 22, 2025

SECAUCUS, N.J. , April 1, 2025 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), a leader in diagnostic information services, announced that it will report first quarter 2025 financial resul...

1 day ago - PRNewsWire

Quest Diagnostics to Highlight Strategic Priorities to Drive Sustainable Growth and Deliver Long-term Shareholder Value at 2025 Investor Day

Provides long-term outlook beyond 2025: Revenues expected to grow at 4-5% compound annual growth rate (CAGR); adjusted diluted earnings per share (EPS) expected to grow at 7-9% CAGR Reaffirms guidance...

14 days ago - PRNewsWire

Fresenius Medical Care Announces Divestment of Select Laboratory Assets to Quest Diagnostics

Quest to provide comprehensive dialysis-related laboratory and water testing services to Fresenius Medical Care owned and affiliated clinics in the United States BAD HOMBURG, Germany and SECAUCUS, N.J...

Other symbols: FMS
5 weeks ago - PRNewsWire

Quest Diagnostics to Host Investor Day on March 19, 2025

SECAUCUS, N.J. , Feb. 13, 2025 /PRNewswire/ --  Quest Diagnostics  (NYSE: DGX), a leading provider of diagnostic information services, will host an Investor Day for institutional investors and financi...

6 weeks ago - PRNewsWire

GRAIL and Quest Diagnostics Provide GRAIL's Galleri® Multi-Cancer Early Detection (MCED) Test Through the Quest Diagnostics Test Ordering System

GRAIL's Galleri   Test Now Directly Available to Physicians in the U.S. Through Collaboration With Quest Diagnostics, Delivering a More Streamlined Provider and Patient Experience  MENLO PARK, Calif. ...

Other symbols: GRAL
7 weeks ago - PRNewsWire

Quest Diagnostics Named to Fortune's World's Most Admired Companies List for 11th Consecutive Year

SECAUCUS, N.J. , Jan. 30, 2025 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, today announced that it has been selected as one of the 2025 World'...

2 months ago - PRNewsWire

Quest Diagnostics Incorporated (DGX) Q4 2024 Earnings Call Transcript

Quest Diagnostics Incorporated (NYSE:DGX) Q4 2024 Earnings Conference Call January 30, 2025 8:30 AM ET Company Participants Jim Davis - President & CEO Sam Samad - EVP & CFO Shawn Bevec - VP, IR Conf...

2 months ago - Seeking Alpha

Quest Diagnostics Reports Fourth Quarter and Full Year 2024 Financial Results; Provides Guidance for Full Year 2025; Increases Quarterly Dividend 6.7% to $0.80 Per Share

Fourth quarter revenues of $2.62 billion, up 14.5% from 2023 Fourth quarter reported diluted earnings per share ("EPS") of $1.95, up 14.7% from 2023; and adjusted diluted EPS of $2.23, up 3.7% from 20...

2 months ago - PRNewsWire

Quest Diagnostics Completes Acquisition of the Outreach Lab Services Business of University Hospitals

Physicians and patients to benefit from access to Quest's industry-leading test menu and broad health plan relationships in Ohio SECAUCUS, N.J. and CLEVELAND , Jan. 27, 2025 /PRNewswire/ -- Quest Diag...

2 months ago - PRNewsWire

Quest Diagnostics Names Adrienne Brott Senior Vice President and Chief Quality and Regulatory Affairs Officer

Quality and regulatory veteran of Getinge, BD and J&J joins the Quest Diagnostics executive team SECAUCUS, N.J. , Jan. 8, 2025 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), a leading provider of diag...

3 months ago - PRNewsWire

Quest Diagnostics to Release Fourth Quarter and Full Year 2024 Financial Results on January 30, 2025

SECAUCUS, N.J. , Jan. 2, 2025 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), a leader in diagnostic information services, announced that it will report fourth quarter and full year 2024 f...

3 months ago - PRNewsWire

Quest Diagnostics to Speak at the 7th Annual Evercore HealthCONx Conference

SECAUCUS, N.J. , Dec. 3, 2024 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), a leader in diagnostic information services, announced that Jim Davis, Chairman, CEO and President, will speak...

4 months ago - PRNewsWire

Quest Diagnostics Launches Health Coaching on questhealth.com to Help Individuals Take Control of Their Health

New service takes the guesswork out of achieving one's health goals by empowering individuals to pair Quest lab results with personalized coaching SECAUCUS, N.J,, Dec. 3, 2024 /PRNewswire/ -- Personal...

4 months ago - PRNewsWire

15 stocks — including Palantir and Nvidia — whose sales estimates have risen the most this earnings season

Other companies whose consensus 2025 revenue estimates have increased the most include BlackRock and Coterra Energy.

4 months ago - Market Watch

Augurex Life Sciences and Quest Diagnostics Collaborate to Improve Rheumatoid Arthritis Diagnosis and Management

VANCOUVER, British Columbia--(BUSINESS WIRE)-- #AxialSpondyloarthritis--Augurex Life Sciences Corp., a leader in autoimmune biomarker-based diagnostics, today announced that it has formed a nonexclusi...

4 months ago - Business Wire

Quest Diagnostics Declares Quarterly Cash Dividend

SECAUCUS, N.J. , Nov. 12, 2024 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), a leader in diagnostic information services, today announced that its Board of Directors declared a quarterly cash dividen...

5 months ago - PRNewsWire

Quest Diagnostics Has Massive Secular Tailwinds And A Strong Base

Quest Diagnostics benefits from an aging population, driving increased lab testing volumes, particularly in genetic testing, and offers a 2.0% dividend yield. DGX's M&A strategy, including the LifeLab...

5 months ago - Seeking Alpha

Quest Diagnostics: Organic Growth Leads To Q3 Earnings Beat

Quest Diagnostics reported strong Q3 earnings, with an 8.5% revenue increase and a 3.6% rise in diluted EPS, beating Street expectations. The company raised its 2024 revenue guidance and expects signi...

5 months ago - Seeking Alpha

US lab operator Quest Diagnostics to launch bird flu test at end of October

Lab operator Quest Diagnostics said on Wednesday it will launch a test for H5N1 bird flu at the end of October after the U.S. Centers for Disease Control and Prevention (CDC) gave it contracts to supp...

5 months ago - Reuters

Quest Diagnostics Awarded CDC Contracts for H5 Avian Influenza and Oropouche Virus Test Development

Quest to develop laboratory tests and support public health reporting and laboratory readiness for CDC's preparedness strategy; Company to introduce clinical testing for avian flu later this month bas...

5 months ago - PRNewsWire

Overlooked Stock: DGX

One of the biggest earnings movers from Tuesday: Quest Diagnostics (DGX). The lab & testing company beat on the top-and-bottom line in its 3Q report, as shares surged to multi-month highs.

5 months ago - Schwab Network

Quest Diagnostics (DGX) Q3 2024 Earnings Call Transcript

Quest Diagnostics Incorporated (NYSE:DGX) Q3 2024 Earnings Conference Call October 22, 2023 8:30 AM ET Company Participants Jim Davis - President, Chief Executive Officer Sam Samad - Executive Vice P...

5 months ago - Seeking Alpha

Quest Diagnostics CEO Touts 'New Customer Wins' In Q3, Expects Earnings Growth In 2025

Quest Diagnostics Inc  DGX posted third-quarter adjusted earnings per share of $2.30, beating the consensus of $2.26.

5 months ago - Benzinga